By Priscila Mayumi Kashiwabara

29 de May de 2020

Biologics and biosimilars in Brazil – the strategic questions

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil – the strategic questions". This article first appeared in IAM Life Sciences: Key issues for senior life sciences executives 2020, a supplement to IAM, published by Law Business Research – IP Division.

Click below to access the full chapter.

See file

Back

Last by Priscila Mayumi Kashiwabara

17 de June de 2025

Brazil Ratifies the Budapest Treaty: A Strategic Step to Strengthen Biotechnological Innovation

On June 11th, 2025, the Brazilian Senate approved Legislative Decree No. 466/2022, ratifying Brazil’s accession to the Budapest Treaty on the International … Brazil Ratifies the Budapest Treaty: A Strategic Step to Strengthen Biotechnological Innovation

29 de May de 2025

Kasznar Leonardos was ranked on IAM Patent 1000

We are proud to announce that we have been ranked in the IAM Patent 1000 2025, a specialized ranking in the field … Kasznar Leonardos was ranked on IAM Patent 1000

15 de April de 2025

Federal Senate approves Bill Extending Plant Variety Protection Term, but Chamber of Deputies Approval is Still Required

The Federal Senate has approved a bill (PLS nº 404/2018) that extends the protection period for new plant varieties (cultivars). According to … Federal Senate approves Bill Extending Plant Variety Protection Term, but Chamber of Deputies Approval is Still Required